期刊文献+

清化方改善代谢综合征人群氧化应激水平的临床研究 被引量:12

Clinical Research on Antioxidant Activities of Qing-Hua Decoction in Patients with Metabolic Syndrome
下载PDF
导出
摘要 目的评价清化方对代谢综合征人群氧化应激水平的作用及可能途径。方法采用随机双盲平行安慰剂对照的方法,通过8周临床观察,比较治疗前后丙二醛(MDA)、超氧化物歧化酶(SOD)、谷胱甘肽(GSH)和谷胱甘肽过氧化物酶(GSH-Px)的变化。结果干预前两组BMI、WHR、血压、HbA1c、血脂等指标具有可比性;治疗组血清MDA水平下降,对照组上升(P=0.046);治疗组血清SOD水平下降低于对照组(P=0.038);两组GSH、GSH-Px变化无差异(P>0.05)。结论清化方对于代谢综合征人群具有一定的抗氧化作用,其作用环节与抗氧化酶SOD相关。 Objective To evaluate the antioxidant activities of Qing-Hua decoction in patients with MS.Methods A randomized,double-blind,placebo-controlled test was conducted.Through observations for 8 weeks,we measured changes of serum concentrations of SOD,GSH,GSH-px and MDA between the two groups.Results Before therapy,there were no significant difference in BMI,WHR,blood pressure,HbA1c and blood lipid between groups(P0.05).After 8-week duration,serum level of MDA was decreased in treatment group.But the placebo group was on the other hand(P=0.046).Serum actiuity of SOD was decreased in the two groups,while changes in treatment group was less(P=0.038).There were no significant differences in changes of serum concentrations of GSH and GSH-px between the two groups.Conclusion Qing-Hua decoction can be used as an antioxidant in patients with MS.The efficacy can be resulted to increase of SOD.
出处 《时珍国医国药》 CAS CSCD 北大核心 2010年第3期680-681,共2页 Lishizhen Medicine and Materia Medica Research
基金 上海市教委科研项目(No.06cz028)
关键词 代谢综合征 抗氧化 清化方 Metabolic syndrome Antioxidant Qing-Hua decoction
  • 相关文献

参考文献5

二级参考文献47

  • 1Vasdev S,Ford CA,Longerich L,et al. Role of aldehydes in fructose induced hypertensiorn. Mol Cell Biochem,1998,181:1.
  • 2Amer P. Insulin resistance in type 2 diabetes: role of fatty acids. Diabetes Metab Res Rev, 2002,18 (2) :S5.
  • 3Boden G. Free fatty acids-The link between obesity and insulin resistance. Endocr Pract, 2001,7: 44.
  • 4Hotamisligil GS. Molecular mechanisms of insulin resistance and the role of the adipocyte. Int J Obes Relat Metab Disord, 2000,24 (4): 23.
  • 5Qi C,Pekala P H. Tumor necrosis factor-alpha-induced insulin resistance in adipocytes. Proc Soc Exp Biol Med,2000,223: 128.
  • 6Mahler RJ,Adler ML. Type 2 diabetes mellitus: update on diagnosis, pathophysiology, and treatment. J Clin Endoerinol Metab, 1999,84 : 1165.
  • 7MARITIM A C, SANDERS R A, WATKINS J B 3rd.Diabetes, oxidative stress, and antioxidants: a review[J].J Biochem Mol Toxicol,2003,17(1):24-38.
  • 8ROBERTSON R P, HARMON J,TRAN P O,et al.Glucose toxicity in beta-cells: type 2 diabetes, good radicals gone bad, and the glutathione connection[J].Diabetes,2003, 52(3):581-587.
  • 9KAJIMOTO T, KANETO H. Role of oxidative stress in pancreatic beta-cell dysfunction-[J].Ann N Y Acad Sci,2004,1011:168-176.
  • 10EVANS J L,GOLDFINE I D,MADDUX B A,et al.Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction-[J]. Diabetes, 2003,52(1):1-8.

共引文献80

同被引文献187

引证文献12

二级引证文献60

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部